Targeting regulated cell death in aortic aneurysm and dissection therapy

Pharmacol Res. 2022 Feb:176:106048. doi: 10.1016/j.phrs.2021.106048. Epub 2021 Dec 28.

Abstract

Regulated cell death (RCD) is a basic biological phenomenon associated with cell and tissue homeostasis. Recent studies have enriched our understanding of RCD, and many novel cell death types, such as ferroptosis and pyroptosis, have been discovered and defined. Aortic aneurysm and dissection (AAD) is a life-threatening condition, but the pathogenesis remains largely unclear. A series of studies have indicated that the death of smooth muscle cells, endothelial cells and inflammatory cells participates in the development of AAD and that corresponding interventions could alleviate disease progression. Many treatments against cell death have been used to impede the process of AAD in vitro and in vivo, which provides strategies to protect against this condition. In this review, we focus on various types of regulated cell death and provide a framework of their roles in AAD, and the information contributes to further exploration of the molecular mechanisms of AAD.

Keywords: Aortic aneurysm and dissection; Apoptosis; Autophagic cell death; Endothelial cells; Regulated cell death; Smooth muscle cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Aortic Aneurysm*
  • Aortic Dissection*
  • Humans
  • Regulated Cell Death*